爱德士实验室
IDXX
560.36
+13.18
+2.41%
爱德士实验室
US · IDXX
#543 按市值排名
上市于 1970
560.36
+13.18
+2.41%
实时 - 追踪5344个代码 - 心跳于49秒前
· 2026-10-16 19:30
✦ 量化股权信号 计算方式说明
减持
- 最近一期(2026/Q3)披露持股的机构数量减少了7家。
- 机构持股总比例下降了0.6个百分点。
机构持股
- 机构持股比例
- 97.00% -0.57pp
- 机构数量
- 1,612 -7
- 数据截至
- 2026/Q3 较上一报告期
持股变动 vs 资金流向
方向一致机构在上一报告期减持了股份,同时该股在最近20个交易日的主力资金呈净流出——两者方向一致。
机构持股变动数据按季度发布且存在滞后;资金流向数据为每日更新。请将其作为方向性的交叉验证参考,而非精确的择时信号。
持股人类型
Mutual Fund83.21%
Hedge Fund3.87%
Public Company3.26%
Government Pension Fund2.96%
Private Company1.72%
Family Office/Trust0.57%
Sovereign Wealth Fund0.49%
Insurance Company0.41%
Individual/Insider0.26%
Other3.24%
主要股东 截至 2026-06-30
BlackRock
10.37% · 8.17M 股
Vanguard Capital Management, LLC
7.11% · 5.60M 股
Vanguard Portfolio Management, LLC
4.95% · 3.90M 股
State Street Global Advisors
4.76% · 3.75M 股
Invesco Capital Management LLC
3.99% · 3.14M 股
Geode Capital Management, LLC
3.25% · 2.56M 股
Baron Capital Group, Inc.
2.51% · 1.98M 股
UBS Asset Management
1.62% · 1.28M 股
William Blair Investment Management, LLC
1.55% · 1.22M 股
Arrowstreet Capital, Limited Partnership
1.35% · 1.07M 股
条形长度是相对于此处列出的最大股东而言,并非相对于公司100%股权。
内部人持股
共追踪50份申报 · 36次买入 · 14次卖出
| 姓名 | 职务 | 持股比例 |
|---|---|---|
| Jonathan Mazelsky | Chief Executive Officer | 0.11% |
| Brian McKeon | Chief Financial Officer | 0.03% |
| Nimrata Hunt | Executive Vice President of Strategy, Sector Development & Global Operations | 0.02% |
| Michael Erickson | Senior VP & GM of Point of Care Diagnostics | 0.02% |
| George Fennell | Senior VP and GM of Companion Animal Group Customer Facing Organization for Americas & Europe | 0.01% |
| Lawrence Kingsley | Independent Non-Executive Chairperson | 0.01% |
| Sophie Vandebroek | Independent Director | 0.01% |
| Michael Lane | Executive VP and GM of Reference Laboratories & Information Technology | 0.01% |
| Sharon Underberg | Executive VP, General Counsel, & Corporate Secretary | 0.01% |
| Andrew Emerson | Senior Vice President of Corporate and CAG Finance | 0.01% |
内部人交易 最近的 Form 4 申报记录
| 日期 | 姓名 | 职务 | 类型 | 股数 | 价格 |
|---|---|---|---|---|---|
| 2026-09-03 | Lawrence Kingsley | Independent Non-Executive Chairperson | Derivative Exercise and Sale | -2,203 | $114.17–532.08 |
| 2026-08-19 | Andrew Emerson | Senior Vice President of Corporate and CAG Finance | Derivative Exercise and Sale | -86 | $178.26 |
| 2026-08-19 | Andrew Emerson | Senior Vice President of Corporate and CAG Finance | Derivative Exercise and Retained | +179 | $178.26 |
| 2026-07-29 | Joseph Hooley | Independent Director | Other Acquisition | +49 | $558.80 |
| 2026-05-31 | George Fennell | Senior VP and GM of Companion Animal Group Customer Facing Organization for Americas & Europe | Derivative Exercise and Sale | -284 | $566.79 |
| 2026-05-31 | George Fennell | Senior VP and GM of Companion Animal Group Customer Facing Organization for Americas & Europe | Derivative Exercise and Retained | +355 | -- |
| 2026-05-11 | Daniel Junius | Independent Director | Other Derivative Acquisition | +234 | -- |
| 2026-05-11 | Daniel Junius | Independent Director | Other Derivative Acquisition | +525 | $533.92 |
| 2026-05-11 | Bruce Claflin | Independent Director | Other Derivative Acquisition | +234 | -- |
| 2026-05-11 | Bruce Claflin | Independent Director | Other Derivative Acquisition | +525 | $533.92 |
| 2026-05-11 | Stuart Essig | Independent Director | Other Derivative Acquisition | +234 | -- |
| 2026-05-11 | Stuart Essig | Independent Director | Other Derivative Acquisition | +525 | $533.92 |
| 2026-05-11 | Joseph Hooley | Independent Director | Other Derivative Acquisition | +234 | -- |
| 2026-05-11 | Joseph Hooley | Independent Director | Other Derivative Acquisition | +525 | $533.92 |
| 2026-05-11 | Lawrence Kingsley | Independent Non-Executive Chairperson | Other Derivative Acquisition | +309 | -- |
| 2026-05-11 | Lawrence Kingsley | Independent Non-Executive Chairperson | Other Derivative Acquisition | +693 | $533.92 |
| 2026-05-11 | Sophie Vandebroek | Independent Director | Other Derivative Acquisition | +234 | -- |
| 2026-05-11 | Sophie Vandebroek | Independent Director | Other Derivative Acquisition | +525 | $533.92 |
| 2026-05-11 | Irene Chang Britt | Independent Director | Other Derivative Acquisition | +234 | -- |
| 2026-05-11 | Irene Chang Britt | Independent Director | Other Derivative Acquisition | +525 | $533.92 |
Form 4 申报记录,每家公司显示最新的一批。"Other Derivative Acquisition"(其他衍生品获取)类目多为限制性股票/期权归属,并非公开市场买入——具体类型见"类型"列。
报价时间 2026-10-16 19:30:05 · 仅供参考,不构成投资建议,也未考虑您的具体情况。
爱德士实验室 讨论区 0 条评论